Included in Forbes Israel’s “Best Doctors” List (2025)
Medical Oncologist | Radiotherapist | Director of Cancer Center
Areas of Expertise
Professor Raanan Berger specializes in medical oncology and radiation therapy, with a strong focus on genitourinary cancers and translational research:
Genitourinary Oncology
Advanced treatment of prostate and related cancers
Prostate Cancer
Comprehensive care including systemic therapy and radiotherapy
Oncology & Radiotherapy
Personalized cancer treatment using modern therapeutic approaches
Molecular Oncology Research
Study of prostate and breast tumorigenesis mechanisms
About the Doctor
Professor Raanan Berger is a leading medical oncologist and radiotherapist, serving as the Director of the Cancer Center at Sheba Medical Center.
He also heads the clinical research unit within the Institute of Oncology and Radiotherapy, where he is actively involved in advancing innovative cancer therapies.
Prof. Berger has played a key role in developing a comprehensive patient support program, integrating medical treatment with psychological and social care. This multidisciplinary model ensures that patients and their families receive not only cutting-edge oncology care, but also continuous emotional and supportive guidance throughout the treatment process.
He leads the genitourinary oncology program, with a particular focus on prostate cancer, and runs a basic and translational research laboratory investigating molecular mechanisms involved in prostate and breast cancer development.
Professor Berger is the co-author of over 20 peer-reviewed scientific publications.
Education and Training
MD and PhD, School of Medicine, Tel Aviv University, Israel
Clinical training in Medical Oncology and Radiotherapy, Sheba Medical Center
Postdoctoral fellowship, Dana-Farber Cancer Institute, Harvard Medical School
During his fellowship, Prof. Berger combined clinical work in prostate cancer treatment (in collaboration with Dr. Philip Kantoff) with advanced research in molecular oncology in the laboratory of Dr. William C. Hahn.
Board Certifications
Oncology
Professional Memberships
Member of European Society for Medical Oncology (ESMO)
Member of American Society of Clinical Oncology (ASCO)
Research & Publications
Professor Berger has contributed to important clinical and scientific research, including:
Classification of high-risk vs. very high-risk prostate cancer and its impact on outcomes of radiotherapy and androgen deprivation therapy
Research on inherited mutations in BRCA1 and BRCA2 genes in large international cohorts